About
Technology
Issues
FAQ
Search
Scientometrics
Impact Factor
Discipline Ranks
h
-index
g
-index
Articles
Citations
Article Citations
Citation Distribution
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
Citing Bodies
Top Citing Authors
Top Citing Institutions
Top Citing Schools
Top Citing Journals
Top Citing Disciplines
exaly
›
Journals
›
Multiple Sclerosis International
›
top-articles
Multiple Sclerosis International
1.4
(top 50%)
impact factor
199
(top 50%)
papers
3.8K
(top 20%)
citations
33
(top 20%)
h
-index
1.6
(top 50%)
extended IF
206
all documents
4.0K
doc citations
50
(top 20%)
g
-index
Top Articles
#
Title
Journal
Year
Citations
1
Meta-Analysis of Three Different Types of Fatigue Management Interventions for People with Multiple Sclerosis: Exercise, Education, and Medication
Multiple Sclerosis International
2014
159
2
DTI Measurements in Multiple Sclerosis: Evaluation of Brain Damage and Clinical Implications
Multiple Sclerosis International
2013
118
3
Retinal Damage in Multiple Sclerosis Disease Subtypes Measured by High-Resolution Optical Coherence Tomography
Multiple Sclerosis International
2012
113
4
The Contribution of Immune and Glial Cell Types in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis
Multiple Sclerosis International
2014
85
5
Measuring the Quality of Life in Patients with Multiple Sclerosis in Clinical Practice: A Necessary Challenge
Multiple Sclerosis International
2013
81
6
Plasma Exchange in Severe Attacks of Neuromyelitis Optica
Multiple Sclerosis International
2012
77
7
Biomarkers in Multiple Sclerosis: An Up-to-Date Overview
Multiple Sclerosis International
2013
76
8
Brain Abnormalities in Neuromyelitis Optica Spectrum Disorder
Multiple Sclerosis International
2012
71
9
Epidemiology of Neuromyelitis Optica in the World: A Systematic Review and Meta-Analysis
Multiple Sclerosis International
2015
69
10
Correlations between MRI and Information Processing Speed in MS: A Meta-Analysis
Multiple Sclerosis International
2014
67
11
Activities-Specific Balance Confidence in People with Multiple Sclerosis
Multiple Sclerosis International
2012
66
12
Gait Variability and Multiple Sclerosis
Multiple Sclerosis International
2013
63
13
Serum Metabolic Profile in Multiple Sclerosis Patients
Multiple Sclerosis International
2011
62
14
Effects of Adjunct Low-Dose Vitamin D on Relapsing-Remitting Multiple Sclerosis Progression: Preliminary Findings of a Randomized Placebo-Controlled Trial
Multiple Sclerosis International
2012
60
15
Adding to the Burden: Gastrointestinal Symptoms and Syndromes in Multiple Sclerosis
Multiple Sclerosis International
2013
60
16
Ultrahigh-Field MR (7 T) Imaging of Brain Lesions in Neuromyelitis Optica
Multiple Sclerosis International
2013
57
17
Internet Usage by Patients with Multiple Sclerosis: Implications to Participatory Medicine and Personalized Healthcare
Multiple Sclerosis International
2010
56
18
The Impact of Comorbid Depression on Adherence to Therapy for Multiple Sclerosis
Multiple Sclerosis International
2011
55
19
The Therapeutic Potential of the Ketogenic Diet in Treating Progressive Multiple Sclerosis
Multiple Sclerosis International
2015
55
20
Outcome Measures in Relapsing-Remitting Multiple Sclerosis: Capturing Disability and Disease Progression in Clinical Trials
Multiple Sclerosis International
2014
54
21
Treadmill Training in Multiple Sclerosis: Can Body Weight Support or Robot Assistance Provide Added Value? A Systematic Review
Multiple Sclerosis International
2012
53
22
Predicting Falls in People with Multiple Sclerosis: Fall History Is as Accurate as More Complex Measures
Multiple Sclerosis International
2013
46
23
Gray Matters in Multiple Sclerosis: Cognitive Impairment and Structural MRI
Multiple Sclerosis International
2014
46
24
Spatial Analysis of Global Prevalence of Multiple Sclerosis Suggests Need for an Updated Prevalence Scale
Multiple Sclerosis International
2014
44
25
Stride-Time Variability and Fall Risk in Persons with Multiple Sclerosis
Multiple Sclerosis International
2015
44
26
Iron and Neurodegeneration in Multiple Sclerosis
Multiple Sclerosis International
2011
40
27
Optical Coherence Tomography in Multiple Sclerosis and Neuromyelitis Optica: An Update
Multiple Sclerosis International
2011
40
28
Neurofilament Proteins as Body Fluid Biomarkers of Neurodegeneration in Multiple Sclerosis
Multiple Sclerosis International
2011
39
29
The Clinical Relevance of Force Platform Measures in Multiple Sclerosis: A Review
Multiple Sclerosis International
2013
39
30
Fatigue, Tiredness, Lack of Energy, and Sleepiness in Multiple Sclerosis Patients Referred for Clinical Polysomnography
Multiple Sclerosis International
2012
38
31
Assessment of Definitions of Sustained Disease Progression in Relapsing-Remitting Multiple Sclerosis
Multiple Sclerosis International
2013
38
32
Quantitative Magnetic Resonance Imaging of Cortical Multiple Sclerosis Pathology
Multiple Sclerosis International
2012
36
33
Applying an Open-Source Segmentation Algorithm to Different OCT Devices in Multiple Sclerosis Patients and Healthy Controls: Implications for Clinical Trials
Multiple Sclerosis International
2015
35
34
Intrathecal IgG Synthesis: A Resistant and Valuable Target for Future Multiple Sclerosis Treatments
Multiple Sclerosis International
2015
35
35
The Role of Wearable Devices in Multiple Sclerosis
Multiple Sclerosis International
2018
35
36
Neuroimaging of Natalizumab Complications in Multiple Sclerosis: PML and Other Associated Entities
Multiple Sclerosis International
2015
34
37
Hyperacute Corticosteroid Treatment of Optic Neuritis at the Onset of Pain May Prevent Visual Loss: A Case Series
Multiple Sclerosis International
2011
33
38
Symptoms and Association with Health Outcomes in Relapsing-Remitting Multiple Sclerosis: Results of a US Patient Survey
Multiple Sclerosis International
2014
33
39
Induced Brain Plasticity after a Facilitation Programme for Autobiographical Memory in Multiple Sclerosis: A Preliminary Study
Multiple Sclerosis International
2012
31
40
Infodemiology and Infoveillance of Multiple Sclerosis in Italy
Multiple Sclerosis International
2013
30
41
Pregnancy and the Use of Disease-Modifying Therapies in Patients with Multiple Sclerosis: Benefits versus Risks
Multiple Sclerosis International
2016
30
42
Potential Impact of B Cells on T Cell Function in Multiple Sclerosis
Multiple Sclerosis International
2011
28
43
Gray Matter Pathology in MS: Neuroimaging and Clinical Correlations
Multiple Sclerosis International
2013
28
44
The Effect of Community Exercise Interventions for People with MS Who Use Bilateral Support for Gait
Multiple Sclerosis International
2014
28
45
Evaluating the Use of Optical Coherence Tomography in Optic Neuritis
Multiple Sclerosis International
2011
27
46
Falls and Physical Activity in Persons with Multiple Sclerosis
Multiple Sclerosis International
2012
27
47
Fatigue and Sleep-Disordered Breathing in Multiple Sclerosis: A Clinically Relevant Association?
Multiple Sclerosis International
2013
27
48
Management of Multiple Sclerosis in the Breastfeeding Mother
Multiple Sclerosis International
2016
27
49
Autoimmune T-Cell Reactivity to Myelin Proteolipids and Glycolipids in Multiple Sclerosis
Multiple Sclerosis International
2013
26
50
The Evidence for Hypoperfusion as a Factor in Multiple Sclerosis Lesion Development
Multiple Sclerosis International
2013
25
site/software ©
exaly
; All materials licenced under
CC by-SA
.